Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer.
Shikata S, Murata T, Yoshida M, Hashiguchi H, Yoshii Y, Ogawa A, Watase C, Shiino S, Sugino H, Jimbo K, Maeshima A, Iwamoto E, Takayama S, Suto A.
Shikata S, et al. Among authors: jimbo k.
Sci Rep. 2023 Nov 11;13(1):19669. doi: 10.1038/s41598-023-47033-8.
Sci Rep. 2023.
PMID: 37952045
Free PMC article.